0000920465-17-000081.txt : 20171213 0000920465-17-000081.hdr.sgml : 20171213 20171213210648 ACCESSION NUMBER: 0000920465-17-000081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171211 FILED AS OF DATE: 20171213 DATE AS OF CHANGE: 20171213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Craig A CENTRAL INDEX KEY: 0001370348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 171255049 MAIL ADDRESS: STREET 1: C/O PURE BIOSCIENCE STREET 2: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_151321719471634.xml FORM 4 X0306 4 2017-12-11 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001370348 Johnson Craig A C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 28.1 2017-12-11 4 A 0 10000 0 A 2027-12-11 Common Stock 10000.0 10000 D This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, which shall be fully vested and exercisable on December 11, 2018. /s/ Ryan Murr, by power of attorney for Craig A. Johnson 2017-12-13